Clinical Trials
9 trialsNCT05426798 2022-06-22
Clinical Study of TQB2618 Injection in Combination With Demethylation Drugs in Patients With Recurrent/Refractory Acute Myeloid Leukemia, Myelodysplastic Syndromes
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT02272478 2020-01-23
AML18
Cardiff University
Phase 2/3 Unknown
NCT01211457 2019-07-16
Study of Sapacitabine in Acute Myeloid Leukemia (AML) or Myelodysplastic Syndromes (MDS)
Cyclacel Pharmaceuticals, Inc.
Phase 1/2 Unknown
NCT03356080 2017-11-29
DLAAG in the Treatment of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome With Blast Excess
Shanghai Tong Ren Hospital
Phase 2 Unknown
NCT01277484 2015-11-20
PODAC
Seoul St. Mary's Hospital
Phase 1 Unknown
NCT01806116 2013-03-12
DFMBHSCT
The First Affiliated Hospital of Soochow University
Phase 4 Unknown
NCT01809392 2013-03-12
Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome
The First Affiliated Hospital of Soochow University
Phase 2/3 Unknown
NCT01133886 2010-09-03
DEC-MDS
King's College London
Phase 2 Unknown
NCT00043134 2010-04-13
Low-Dose Decitabine Compared With Standard Supportive Care in Treating Older Patients With Myelodysplastic Syndrome
National Cancer Institute (NCI)
Phase 3 Unknown